Description

NSE announces listing of commercial papers from multiple issuers including HSBC Investdirect, HDFC Securities, Export Import Bank, Tata Projects, Godrej Properties, Godrej Industries, Astec LifeSciences, Kotak Securities, and Axis Securities on the debt market segment.

Summary

NSE has admitted 10 privately placed commercial papers to dealings on the Debt Market Segment effective November 25, 2025. The securities include commercial papers from HSBC Investdirect Financial Services (3 series), HDFC Securities, Export Import Bank of India, Tata Projects, Godrej Properties, Godrej Industries, Astec LifeSciences, Kotak Securities, and Axis Securities with redemption dates ranging from February to May 2026.

Key Points

  • Total of 88,600 commercial paper securities listed with face value of ₹5,00,000 each
  • All securities allotted on November 24-25, 2025
  • Redemption periods range from 90 to 182 days
  • Issue prices range from ₹4,83,160 to ₹4,92,473.50 per security
  • Largest issue: Export Import Bank of India (50,000 securities worth ₹250 crore at face value)
  • Listings made pursuant to Regulation 3.1.1 of NSE Debt Market (Trading) Regulations

Regulatory Changes

No regulatory changes introduced. This is a routine listing notification.

Compliance Requirements

No new compliance requirements. Members are notified of the new security codes for trading purposes on the debt market segment.

Important Dates

  • Effective Date of Listing: November 25, 2025
  • Allotment Dates: November 24-25, 2025
  • Redemption Dates:
    • February 23, 2026: HIFSIL Sr 34, TPL Sr 201, GPL Sr 92, GIL Sr 120, ASL Sr 51
    • February 24, 2026: KSL Sr 192
    • March 3, 2026: HSL
    • May 22, 2026: ALSL Sr 189
    • May 25, 2026: HIFSIL Sr 35, EXIM Sr 5

Impact Assessment

Minimal market impact. This is a standard administrative notification informing members about newly listed debt securities. The listing provides additional short-term debt instruments for institutional investors and enables secondary market trading of these commercial papers. The securities represent routine corporate funding activities with no implications for equity markets or broader regulatory framework.

Impact Justification

Routine listing notification for privately placed commercial papers with no market-wide implications or regulatory changes